Do intravascular ultrasound predictors for target lesion revascularization apply to saphenous vein grafts?  by Castagna, Marco T. et al.
JACC March  6,  2002 
rates. However, no cost advantage is noted with IVUS-gulded stent placement when acute 
procedural costs and TLR-associated costs are compared with anglegraphy-guided stent 
placement. 
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8~>0-3  Cost-Effectivenses of Intracoronary Ultrasound for  
Percutsneous Coronary Interventions: Economic 
Analysis of the Randomized SIPS Trial 
Christian Mueller, John M. Hodgson, Heinz J. Buettner, Stephan Marsch, HeLmut 
Roskamm, Herz-Zentrum, Bad Krezingan, Germany, University Hospital, Basel, 
Switzerland. 
Background: The SIPS-trial included a prospectively designed economic analysis to investi- 
gate whether outine IVUS-guidance intervention iscost-effective. 
Methods: Consecutive patients (n=269) with 356 lesions were randomly assigned to receive 
previsional stenting with angiographlc guidance only (ANGLO) or with IVUS guidance. 
Results: The two-year MACE free survival (effectiveness) was significantly higher in the 
WUS-gulded group (80% versus 69%, p=0.04). In-hospital costs for procedural personnel, 
capital and disposable equipment were higher in the IVUS group. This was offset by lower 
costs for inpatient care and urgent arget vessel revasculadzation i the IVUS group. There- 
fore, total in-hcepltat cost was comparable [$5245e.2256 (IVUS) versus $4776¢2961 
(ANGLO), S/patient, p=0.15]. During two-year follow-up costs for cardiac hospitalizations, 
medication and indirect costs were similar. This resulted in identical total costs over the two- 
year period [$15.947¢8545 (IVUS) versus $15.103±9954 (ANGLO), S/patient, p=0.89]. The 
cost-effectivenass ratio calculated to $19.823 par MACE-free survival with IVUS and to 
$23.190 par MACE-free survival with ANGLO. Bootstrapping revealed a 61% probability of 
IVUS being less expensive and more effective (Figure). Sensitivity analysis showed that the 
cost-effectiveness of IVUS was robust o changes in several variables. 
Conclusion: When used in a provisional stenting strategy, routine IVUS imaging is cost-effec- 
tive. 
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850-4 Do Intravascular Ultrasound Predictors for  Target 
Lesion Revascularlzetion Apply to Saphenous Vein 
Grafts? 
Marco T. Ceataona. Gary S. Mintz, Ellen Pinnow, Akiko Maehara, Javed M. Ahmed, 
Euganio Stabile, Natalie Gevoddan, Danlele Claus, Marfina Gillerd, William O. Soddath, 
Lowell F. Satier, Augusto D. Pichard, Nell J. Weissman, Washington Hospital Center, 
Washington, Dist of Columbia, Cardiovascular Research Foundation, New York, New York. 
Background: Previous studies have defined the predictors of target lesion revascular- 
ization (TLR) after stent implantation in native coronary arteries to include intravascular 
ultrasound (IVUS) reference lumen dimensions and lesion site plaque burden, remodel- 
ing, and final lumen dimensions.Methods end Results: To determine whether these pre- 
dictors of TLR also apply to sapbenous vein graft (SVG) stanoses, we reviewed the IVUS 
findings in 313 SVG lesions in 275 pts before and after stent implantation. Lesion and 
proximal and distal reference measurements included external elastic membrane (EEM), 
lumen, and plaque (EEM-lumen) areas. Lesion site remodeling index was determined by 
dividing lesion EEM by average reference segment. Positive remodeling was defined 
>1.0 and intermediate/negative r modeling as _<1.0. Baseline characteristics uch as 
gender, hypertension, diabetes, tobacco use, hypercholesterolemie, renal insufficiency 
(craatinina serum level >1.2), family history, and lesion site location (anastomosis, SVG 
body and ostium) were similar in the lesions with and without TLR. IVUS findings are 
shown in the Table. Importantly, these IVUS measurements also did not predict CK-MB 
elevation after stent implantation. 
Conclusion: Conventional IVUS predictors of TLR in native artedas do not apply to SVG 
lesions treated with stant implantation. 
TLR NoTLR p 
N=31 lesions N=179 lesions 
Average Reference Lumen CSA mm 2 9.74±3.26 11.16±4.81 0.11 
Average Reference Plaque Burden (%) 32±5 33±7 0.7 
Lesion Plaque Burden (%) 68±9 71 ±13 0.20 
Average References Plaque CSA mm 2 4.84±2.09 5.57±2.69 0.15 
Final Lumen CSA mm 2 7.34±2.58 8.35±3.0 0. t 1 
Positive Remodeling 6 (20%) 35 (20'/0) 1.0 
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850-5 Intravascular Ultrasound Guidance Optimizes Cuffing 
Balloon Angloplasty 
yuzuru Takado, Sam Bastani, Oren T. Guftman, Jesse W. Currier, Lawrence A. Yeatman, 
Kathy McCIoy, Annette Davis, Devendra K. Vora, Jonathan M. Tobis, UCLA Center for 
Health Sciences, Los Angeles, California. 
Background. The purpose of the present study was to test whether intravascular ultra- 
sound (IVUS) guidance for Cutting Balloon (CB) angioplesty could improve the acute 
results of percutanaous coronary interventions (PCI). IVUS guidance may be useful dur- 
ing PCI to optimize angiographic results compared with angiographic guidance alone. 
When using the CB, accurately sizing the device may enhance the dilatation effect yet 
protect against the risk of perforation. 
Methods. CB angioplasty was used on 151 coronary artery lesions from 103 patients. 
The coronary lesions were classified into 2 groups: IVUS guided or angiographic guid- 
ance alone. 
Results. The initial CB success rate was 89% (the CB would not pass through 14 
lesions). In 135 successful esions, the IVUS guided group had a significantly larger MLD 
and less % diameter stenceis than the angiographic guided group. 78 lesions were also 
treated with stents (IVUS guided 37, angiography alone 41). The IVUS guided stent 
group had a larger MLD (3.0-zO.3 ram) than the angiographlc group (2.8-tO.6 mm, p<0.05) 
despite similar reference diameters. One coronary perforation occurred in the angio- 
graphic guidance group. 
Conclusion. By performing IVUS pdor to PCI, the size of the CB can be matched to the 
media diameter thus optimizing the results compared to angiographic guidance alone. 
When the CB diameter is based on IVUS measurements, these improved results may be 
obtained without an increased risk of perforation. 
Cutting Balloon IVUS guided Angiography alone p value 
# of lesions 63 72 
Reference diameter (mm) 2.9-/0.5 2.8:L~.6 n.s. 
MLD (mm) before 0.7:L~.5 0.7i-0.5 n.s. 
after CB 2.1:t:0.5 1.9t"0.5 p<0.05 
final 2.8L~0.4 2.5~0.6 p<0.05 
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850-6 Intravascular Ultrasound Guidance Decreases Target 
Lesion Revaacularizetion in Long-Dif fuse Coronary 
Lesions 
Andrea S. Abizaid, Roxana Mehran, Alexandra J. Lansky, George Dangas, Alaxandrs 
Abizaid, Mohamed Mohamed, Izat Hjazi, Gregg W. Stone, Martin B. Leon, Lenox Hill 
Heart & Vascular Institute, New York, New York, Cardiovascular Research Foundation, 
New York, New York. 
Background: Stenting of long lesions improves procedural results and reduces late recur- 
rence when compared to balloon angioplasty. However, most previous studies have used 
angiographic guidance during stent implantation. Methods: We analyzed 879 patients 
with long lesions (>_20ram) in native coronary arteries that were treated with stent implan- 
tation, 673 with intravascular ultrasound (IVUS)-guidanco (n=673) vs 206 with anglo- 
graphic guidance. Results: Baseline charactaristics (including diabetes and vessel size) 
and major in-hospital complications were similar between the two groups (Table). Proce- 
dural details and acute angiographic and long-term clinical results are shown (Table). 
Conclusions: By using larger slants/balloons at higher pressures, IVUS-guidance during 
stenting of pts with long lesions achieved a superior sngiographic result. This translated 
into a significant improvement in late clinical outcome even though IVUS-guidance 
resulted in implanting more stents/lasion. Thus, it is not the amount of slant metal, but the 
lumen size that determines the need for repeat revasculadzation. 
IVUS-guided Anglo-guided p 
Diabetes, % 34% 35% 0.8 
LAD, % 26% 22% 0.2 
# of stents,n 1.6±0.8 1.3±0.7 0.0001 
Maximum stont/balloon size, mm 1.1 ±0,3 1.0±0.2 0.001 
Maximum inflation pressure, arm 14.5±3.9 12.2±4.3 0.0001 
Angiography 
Lesion length, mm 24±9 25±10 0.16 
Reference diameter, (mm) 3.1±0.8 3.2±1.1 0.4 
Final MLD, mm 2.7±0.9 2.5±1.2 0.04 
Final DS 11±9 20±11 0.0001 
6-month TLR, % 14 20 0.05 
MLD=minimum lumen diameter, DS=diameter stenosis, TLR=target lesion 
revascularization 
